Results 211 to 220 of about 107,975 (358)

Gelatin Nanoparticles-HPMC Hybrid System for Effective Ocular Topical Administration of Antihypertensive Agents. [PDF]

Pharmaceutics, 2020
Esteban-Pérez S, Andrés-Guerrero V, López-Cano JJ, Molina-Martínez I, Herrero-Vanrell R, Bravo-Osuna I.   +5 more
europepmc   +1 more source

Determination of antihypertensive agent, (2R,4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarboxylic acid by high performance liquid chromatography with post-column derivatization with N-(9-acridinyl)maleimide.

, 1984
Tateo Suzuki, Kazuaki Akasaka, Hiroshi Meguro   +2 more
openalex   +2 more sources

Rehabilitation of patients with stroke: summary of SIGN guidance [PDF]

, 2010
Barber, M., Chung, C., Gillespie, D., James, R., Ramsay, S., Smith, L.N.   +5 more
core   +1 more source

Impact of the era of diabetes onset in a national care system on the prevalence of retinopathy and microalbuminuria in people living with type 1 diabetes 15 years post‐diagnosis: A cross‐sectional, real‐world observational study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims This study investigates the impact of the era of diabetes onset on the prevalence of diabetic retinopathy and albuminuria 15 years post‐diagnosis in people living with type 1 diabetes (T1D) within a national healthcare system offering structured multidisciplinary endocrinology care.
Astrid Lavens, Christophe De Block, Philippe Oriot, Jean‐Christophe Philips, Michel Vandenbroucke, Laurent Crenier, Frank Nobels, Chantal Mathieu, on behalf of the Belgian Group of Experts IQED   +8 more
wiley   +1 more source

Survey on trends of use of antihypertensive agents based on DDD (defined daily doses).

, 1987
NANAE SUDO
openalex   +2 more sources

Are there meaningful differences in blood pressure control with current antihypertensive agents? [PDF]

, 2002
Suzanne Oparil
openalex   +1 more source

Cardiovascular and kidney outcomes of GLP‐1 receptor agonists in adults with obesity: A target trial emulation study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) provide cardiovascular and renal benefits in type 2 diabetes, but their real‐world effects in individuals with obesity without diabetes are unclear. This study aimed to evaluate the cardiovascular and kidney outcomes of GLP‐1RAs versus other anti‐obesity medications (AOMs) in adults ...
Huilin Tang, Yiwen Lu, Bingyu Zhang, Ting Zhou, Dazheng Zhang, Jiajie Chen, Yong Chen, David A. Asch, Yong Chen   +8 more
wiley   +1 more source

Antihypertensive agents and cerebral circulation.

, 1989
Masatoshi Fujishima, Seizo Sadoshima, Takao Ishitsuka, Setsuro Ibayashi, Kenichiro Fujii   +4 more
openalex   +2 more sources

Management of Proteinuria in Dogs and Cats with Chronic Kidney Disease [PDF]

, 2016
Atkins, Bakris, Bianchi, Bomback, Brown, Brown, Brown, Brown, Bugbee, Christ, Finco, Grauer, Grauer, Horita, Jacob, Jenkins, Jepson, Jepson, Jonathan Elliott, King, King, Laverman, Lees, Lefebvre, LeVine, Linas, Littman, Maack, McAlister, Mizutani, Nabity, Nakamura, Pollock, Pressler, Ryan, Schjoedt, Schneider, Segev, Segev, Sent, Shelly L. Vaden, Singh, Syme, Tenhundfeld, Toblli, Vaden, Wehner   +46 more
core   +1 more source

Nephrology Crossword: Antihypertensive agents [PDF]

Kidney International, 2016
Kenar D. Jhaveri, Manish K. Saha
openaire   +3 more sources